UTERINE LEIOMYOMA Clinical Trial
Official title:
Influence of the Aromatase Inhibitor Anastrozole and GnRH Analog Goserelin Acetate as Preoperative Treatment of Vaginal Surgical Treatment of Uterine Leiomyoma: Analysis of Intra and Immediate/Late Postoperative Patterns
The investigators aimed to assess if use of aromatase inhibitors could decrease volume of uterine leiomyoma and cause same percentage of adverse effects during its use compared to GnRH analogs.
Uterine leiomyoma is the most prevalent benign gynecologic tumor in women. Standard treatment is surgical (hysterectomy or myomectomy), and depends of many variables. If these tumors are large, preoperative assessment with clinical treatment may be useful in order to decrease its volume, improve hematologic patterns and modify surgical approach (vaginal or abdominal). It is well know that GnRH analogs can cause these goals; however, aromatase inhibitors are new promising drugs which are being used for reducing uterine leiomyoma's volume and few observational studies have shown this fact. The investigators are aiming to compare both treatments in a randomized controlled trial and see if it both treatments are similar or not in decreasing uterine leiomyoma's volume, influencing operative time, blood loss during surgery. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04519593 -
ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma
|
N/A | |
Not yet recruiting |
NCT03219385 -
Directed Ablation of Uterine Fibroids Using a Noninvasive Approach
|
N/A | |
Completed |
NCT01338831 -
Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast Cancer
|
Phase 1 | |
Completed |
NCT01468402 -
Predictive Factors of Pelvic Magnetic Resonance in the Response of Arterial Embolization of Uterine Leiomyoma
|
N/A | |
Completed |
NCT03847077 -
Trial of a Patient Education Tool For Leiomyoma
|
N/A | |
Completed |
NCT00365989 -
MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication
|
Phase 3 | |
Completed |
NCT03751124 -
Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
|
Phase 3 | |
Recruiting |
NCT02495311 -
The Association Between Adenomyosis/Uterine Myoma and Lower Urinary Tract Symptoms
|
||
Completed |
NCT00332033 -
Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids)
|
Phase 2 | |
Completed |
NCT04874246 -
Comparison of Concentration of Vasopressin During Robot-assisted Laparoscopic Myomectomy
|
N/A | |
Not yet recruiting |
NCT04282863 -
Comparison Between Robotic (RM) and Laparoscopic Myomectomy (LM)
|
N/A | |
Recruiting |
NCT06115408 -
Evaluation of Using Dienogest and N-Acetyl Cysteine on the Volume of Uterine Leiomyoma
|
Phase 2/Phase 3 | |
Completed |
NCT02049242 -
Uterine Tourniquet at Open Myomectomy
|
N/A | |
Completed |
NCT02059954 -
Vaginal vs. Laparoscopic Hysterectomy
|
N/A | |
Terminated |
NCT01738724 -
Study of the Efficacy of Dienogest in the Treatment of Uterine Leiomyomas When Compared to Desogestrel and Goserelin
|
Phase 4 | |
Withdrawn |
NCT02736435 -
Treatment of Uterine Fibroids With Magnetic Resonance Guided High Intensity Focused Ultrasound
|
Phase 3 | |
Completed |
NCT04819633 -
Evaluating Serum Sestrin in Leiomyoma Patients
|
||
Completed |
NCT00341848 -
Postpartum Uterine Regression
|
||
Completed |
NCT01715597 -
Study on the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women With Uterine Myoma
|
Phase 3 | |
Completed |
NCT03328260 -
High Intensity Focused Ultrasound in Uterine Myoma
|
N/A |